Incorporating the investigational, oral selective estrogen receptor degrader (SERD) camizestrant at the first sign of ...

When cancer spreads from a primary tumor to new sites throughout the body, it undergoes changes that increase its genetic ...

Survival rates among breast cancer patients whose cancer is detected before it spreads are high, between 86% and 89%. Yet if ...

Men who carry two copies of a common genetic variant are twice as likely to develop dementia than women with the same ...

Data presented at ASCO show that swapping in the oral drug camizestrant for an older therapy helped sustain the benefit of ...

Using the gene scissors CRISPR and stem cells, researchers at Stockholm University and the UK Dementia Research Institute (UK ...

"In patients with compound mutations, the median PFS was 21.0 months for those with common mutations and 18 months for those without common mutations, indicating high efficacy of afatinib against ...

While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

Ancestry and smoking influence genetic mutation rates in children, but parental age remains the strongest factor, a new study ...